Director of Pre-Clinical Services
Precision NanoSystems
Vancouver, British Columbia, Canada
Dr. Jagbir Singh has 15 years of research experience and, has completed >150 projects in formulation development and manufacturing process scale-up. At PNI, Dr Singh leads a team of scientists and staff to develop a diverse range of nanoparticle formulations for application in gene editing, gene therapy, oncology and vaccines. Dr. Singh received his Ph.D. from University of Saskatchewan for his work on the development of topical lipid-based delivery systems for plasmid DNA. During his postdoctoral training at BC Cancer Research Centre, he developed novel injectable liposomal formulations for targeting metastatic breast cancer and pancreatic cancer. He is a recipient of 2014/15 Canadian Breast Cancer Foundation - BC/Yukon Annual Breast Cancer Research Doctoral and Postgraduate Fellowship and, Michael Smith Foundation for Health Research Postdoctoral Fellow, 2015-2017. His work has been published in numerous publications and has received 2012 Gattefossé Canada/CSPS Award in Lipid-Based Drug Delivery. He is a co-inventor on two patent applications.
From Concept to Clinic: Navigating RNA-Lipid Nanoparticle Development
Monday, October 23, 2023
9:30 AM – 10:30 AM ET